2017-03-24,Lifshitz & Miller LLP Announces Investigation Of Cemtrex, Inc., Kitov Pharmaceuticals Holdings LTD, NantHealth, Inc., Omega Protein Corporation, Pearson Plc, Trecora Resources, Trivago N.V. And WPP Plc
2017-03-14,DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Kitov Pharmaceuticals Holdings Ltd. To Contact The Firm
2017-03-10,Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Kitov Pharmaceuticals Holdings Ltd.
2017-03-08,Kitov Announces License Agreement For KIT-302 In South Korea
2017-02-21,INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Kitov Pharmaceuticals Holdings Ltd. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2017-02-13,KTOV STOCK DROP NOTICE: Rosen Law Firm Reminds Kitov Pharmaceutical Holdings Ltd. Investors Of Important Deadline In Class Action - KTOV
2017-02-10,Kitov Announces Settlement Agreement With Minority Shareholder Of Recently Acquired TyrNovo
2017-02-09,Kitov Provides Further Update On Formal Investigation By Israeli Securities Authority
2017-02-08,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Kitov Pharmaceutical Holdings LTD (KTOV) & Lead Plaintiff Deadline: April 10, 2017
2017-02-08,EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Kitov Pharmaceutical Holdings Ltd. - KTOV
2017-02-07,Kitov Announces Initiation Of Formal Investigation By Israeli Securities Authority
2017-02-07,KTOV NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Kitov Pharmaceutical Holdings Ltd. To Contact The Firm
2017-02-07,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Kitov Pharmaceutical Holdings LTD (KTOV)
2017-02-06,EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Kitov Pharmaceutical Holdings Ltd.
2017-02-06,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Kitov Pharmaceutical Holdings Ltd. - KTOV
2017-02-01,Kitov Granted Notice Of Allowance From U.S. Patent & Trademark Office For KIT-302
2017-01-17,Kitov To Host Business Update Call On Monday, January 23, 2017
2017-01-12,Kitov Enters Immuno-Oncology Field Through Acquisition Of TyrNovo
2016-12-07,Kitov Successfully Completes All KIT-302 Testing Required For New Drug Application To U.S. FDA
2016-09-27,Kitov Reports Successful Results For Additional KIT-302 Pharmacokinetic Bioequivalence Study
2016-09-06,Kitov Pharmaceuticals To Present Data From A U.S. Market Assessment For KIT-302
2016-08-17,Kitov Pharmaceuticals Issues First Half 2016 Financial Reports
2016-08-10,Kitov Announces Issuance Of U.S. Patent Securing Long-Term Exclusivity For KIT-302 Ahead Of New Drug Application To The FDA
2016-07-05,Kitov Pharmaceuticals Announces Closing Of A $12 Million Follow-On Public Offering In The U.S.A.
2016-06-29,Kitov Pharmaceuticals Announces Pricing Of $12 Million Follow-On Public Offering In The U.S.A.
2016-06-28,Kitov's Lead Drug KIT-302 Achieves Manufacturing Milestone Ahead Of Planned NDA Filing With U.S. FDA
2016-06-24,Kitov Reports New Data Demonstrating KIT-302 Has Beneficial Effects On Kidney Function
2016-05-27,Kitov Announces Completion Of Manufacturing Pivotal Batches Of KIT-302 Required For Registration In The U.S.
2016-05-12,Kitov Granted Notice Of Allowance From U.S. Patent Office For KIT-302
2016-05-12,Kitov Receives Pre-NDA Meeting Response From FDA For KIT-302, Supporting Its NDA Submission
2016-05-10,Kitov Reports KIT-302 Study Successfully Meets U.S. Food & Drug Administration Bioequivalence Standards
2016-05-04,Kitov Pharmaceuticals To Present At Pioneers 2016, Presented By Joseph Gunnar, In NYC On May 5, 2016
2016-01-11,Kitov Pharmaceuticals To Present At Biotech Showcase In San Francisco On January 11, 2016
2016-01-08,Kitov Pharmaceuticals Appoints Dr. Gil Ben-Menachem As V.P. Of Business Development
2015-12-17,Kitov Pharmaceuticals Reports Additional Data From Its Phase III Trial On The Beneficial Blood Pressure Effects Of KIT-302
2015-12-15,Kitov Pharmaceuticals (KTOV) Stock Soars on Hypertension Drug Trial Results
2015-12-15,Kitov Pharmaceuticals' Pivotal Phase III Trial Successfully Meets Primary Efficacy Endpoint
2015-12-10,Kitov Pharmaceuticals To Announce Interim Results Of The Pivotal Phase III Trial On December 15, 2015 At 7:00am ET
2015-11-25,Kitov Pharmaceuticals Holdings Announces Closing Of U.S. Initial Public Offering
2015-11-20,Kitov Pharmaceuticals Holdings Announces Pricing Of U.S. Initial Public Offering And NASDAQ Listing
,
,
,
,
